The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zoladex LA 10.8 mg Implant

10.8 Base Milligrams Implant

AstraZeneca ABPA1019/027/002

Main Information

Trade NameZoladex LA 10.8 mg Implant
Active SubstancesGoserelin acetate
Strength10.8 Base Milligrams
Dosage FormImplant
Licence HolderAstraZeneca AB
Licence NumberPA1019/027/002

Group Information

ATC CodeL02AE Gonadotropin releasing hormone analogues
L02AE03 goserelin

Status

Authorised/WithdrawnAuthorised
Licence Issued03/01/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back